20
total announcements
APOLLOHOSP.NS · 15 min delayed
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about the proceedings and voting results of the 45th Annual General Meeting (AGM) held on August 25, 2026, through video conference.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 25, 2026, and voting results along with copy of scrutinizers report together with copy of minutes.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about the transcript of the presentation on unaudited financial results for the three months ended June 30, 2026, available on the Company's website.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about the availability of the audio recording of the Analyst call on financial results for the three months ended June 30, 2026, on the Company's website.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about Investor Presentation for the three months ended June 30, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about Presentation of Investor Relations for Q1 FY27, disclosing earnings update for the quarter ended June 30, 2026.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates, including the approval of unaudited financial results, appointment of new statutory auditors, and grant of stock options under the Apollo ESOP Plan 2024.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding a press release dated August 12, 2026, titled "Apollo Hospitals Q1FY27 Results". The company has approved the unaudited financial results for the three months ended June 30, 2026, and appointed M/s Price Waterhouse Chartered Accountants LLP as Statutory Auditors for a term of five years. Additionally, the company has taken note of the proposed transfer of undertaking by Apollo Healthco Limited to its wholly owned subsidiary and granted additional stock options to new employees.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has submitted its financial results for the period ended June 30, 2026, and approved the appointment of new statutory auditors. The company also announced the transfer of a subsidiary's undertaking and the grant of additional stock options under its employee stock option plan.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates related to the 45th Annual General Meeting and e-voting information.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about General Updates, including the submission of Notice of 45th Annual General Meeting (AGM) and Annual Report for the FY 2025-2026, and the confirmation of Interim Dividend and approval for Declaration of Final Dividend.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 25, 2026, to confirm payment of Interim Dividend and to declare final dividend on Equity Shares for the financial year ended March 31, 2026.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has scheduled a conference call for analysts/investors to discuss the unaudited financial results for the three months ended June 30, 2026. The call will be held on August 13, 2026, at 3:00 PM IST.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding 'Certificate under Regulation 74(5) for the period ended 30th June 2026'.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement. The company has passed the resolutions for the Scheme with requisite majority at their respective meetings.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has submitted the Exchange a copy Scrutinizer's report of Court Convened General Meeting held on Jun 24, 2026. The company has informed the Exchange regarding voting results of the meeting of the equity shareholders, secured creditors, and unsecured creditors.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from July 1, 2026, till 48 hours after the announcement/declaration of the unaudited financial results for the quarter ending on June 30, 2026.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement proceedings, including meetings of secured creditors, unsecured creditors, and equity shareholders, held on June 24, 2026, to consider and approve the composite scheme of arrangement amongst Apollo Hospitals Enterprise Limited, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited, under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on Jun 24, 2026, along with a copy of minutes. The meeting was held to consider and approve the composite scheme of arrangement amongst Apollo Hospitals Enterprise Limited, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited, and their respective shareholders and creditors, under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013.
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited has announced a proposed composite scheme of arrangement involving itself and three other entities: Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. This restructuring initiative falls under Sections 230 to 232 of the Companies Act, 2013. While the initial announcement does not disclose specific financial figures or the full details of the scheme, it signals a significant corporate restructuring. Investors should monitor for further disclosures, as such arrangements can impact the company's business segments, asset allocation, and future valuations.